Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Phase of Chronic Myeloid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01368523
What this trial is testing

Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)Ended earlyNCT00002778
What this trial is testing

Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Testing effectiveness (Phase 2)UnknownNCT00335868
What this trial is testing

PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy

Who this might be right for
Leukemia
Jonsson Comprehensive Cancer Center 16
Early research (Phase 1)Looking for participantsNCT06994676
What this trial is testing

CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Who this might be right for
High-risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia (CMML)AML - Acute Myeloid Leukemia+1 more
Crossbow Therapeutics, Inc. 72
Early research (Phase 1)WithdrawnNCT04808115
What this trial is testing

IIT PH1 KDS-1001 in Patients With CML

Who this might be right for
CML (Chronic Myelogenous Leukemia
Duke University
Testing effectiveness (Phase 2)Study completedNCT00036738
What this trial is testing

Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Blastic Phase+7 more
Fred Hutchinson Cancer Center 28
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Early research (Phase 1)Study completedNCT00066326
What this trial is testing

Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Study completedNCT01254578
What this trial is testing

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT04883125
What this trial is testing

Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

Who this might be right for
Chronic Myelogenous Leukemia, BCR-ABL PositiveCML, Chronic Phase
Mansoura University 90
Large-scale testing (Phase 3)Study completedNCT00760877
What this trial is testing

Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)

Who this might be right for
CHRONIC MYELOGENOUS LEUKEMIA
Novartis Pharmaceuticals 207
Testing effectiveness (Phase 2)Study completedNCT00096122
What this trial is testing

Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+20 more
National Cancer Institute (NCI) 95
Testing effectiveness (Phase 2)Study completedNCT01904136
What this trial is testing

Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Gene Mutations+6 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Looking for participantsNCT06409936
What this trial is testing

PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML

Who this might be right for
CML, Chronic PhaseChronic Myeloid Leukemia, Chronic PhaseChronic Myeloid Leukemia, BCR/ABL-Positive+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 160
Large-scale testing (Phase 3)Looking for participantsNCT06423911
What this trial is testing

Study of Olverembatinib (HQP1351) in Patients With CML-CP

Who this might be right for
Chronic Myeloid LeukemiaCMLCML, Chronic Phase
Ascentage Pharma Group Inc. 333
Early research (Phase 1)Looking for participantsNCT06218628
What this trial is testing

Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis+3 more
Fox Chase Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00015834
What this trial is testing

STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveRelapsing Chronic Myelogenous Leukemia
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT00068718
What this trial is testing

Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant

Who this might be right for
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid Leukemia+3 more
Fred Hutchinson Cancer Center 35
Large-scale testing (Phase 3)Ended earlyNCT02108951
What this trial is testing

Study to Assess Efficacy and Safety of Nilotinib 300mg Twice Daily in Patients With Philadelphia Positive Chronic Myeloid Leukaemia (CML) in Chronic Phase Who Are Intolerant to Prior Tyrosine Kinase Inhibitors.

Who this might be right for
Philidelphia Positive Chronic Myeloid Leukaemia
Novartis Pharmaceuticals 20
Early research (Phase 1)Ended earlyNCT00004239
What this trial is testing

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Alliance for Clinical Trials in Oncology 10
Next Page